Ramakrishna Mission Tuberculosis Sanatorium

Details

Name :

Ramakrishna Mission Tuberculosis Sanatorium

Address  :

P.O. Ramakrishna Sanatorium

Town  :

Ranchi

State  :

Jharkhand

Country  :

INDIA

Post Code:

835221

Phone  :

+919431170005

Web URL  :

Ramakrishna Mission Tuberculosis Sanatorium
Specialization
  • Cosmetic Surgery
  • Dentistry
  • Dermatology
  • ENT
  • General Medicine
  • Obestetrician/Gynecologist
  • Ophthalmology
  • Orthopedics
  • Paediatrics
  • Pathology Lab
  • Pulmonology
  • Radiation therapy
  • Sonography
Facilities

Total Number Of Beds : 200

Other Facilities

  • Pathology
  • Ultrasonography

Other Mode Of Therapies

  • Ayurvedic
  • Physiotherapy


Description

The Sanatorium which was opened in 1951 with 32 beds had 280 beds last year with several ancillary departments including a diary and an agricultural farm for the benefit of the patients Its activities are
An inpatient department which treats about 500 male TB cases annually with about 300 cases being treated free of charge and 200 at concessional rates
An outpatient department which treats about 29000 cases annually 27000 of them freeofcharge
An outpatient homoeopathic department which treats about 5800 cases all free annually
A mobile dispensary which treats about 18000 cases all free annually
A library with 5210 books and 27 newspapers and periodicals for inpatients staff
A free middle school Hindi medium for the local adivasi tribal and backward class children about 250 boys and 170 girls and
Observance of the birthday celebrations of Sri Ramakrishna Holy Mother and Swami Vivekananda Jesus Christ and religious festivals like Jagaddhatri Puja etc
Work on common code for heart illness begins

When D Venkatesh a 25yearold Bangalorebased footballer succumbed to a massive cardiac arrest during a football game on March 22 experts in India debated how young Indians in metropolis including Mumbai were contracting more heart ailments But it was anecdotal information the cardiologists were referring to with no data or actual reasons to back up ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More